QNCX Stock Analysis: Buy, Sell, or Hold?
QNCX - Quince Therapeutics, Inc. Common Stock
$0.95
-0.02 (-1.98%)
▼
5d:
+5.41%
30d:
-13.73%
90d:
+919.33%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When QNCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: QNCX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: QNCX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: QNCX is currently trading at $0.95, which is considered slightly low relative to its 30-day fair value range of $0.93 to $1.11.
Technical Outlook: Technically, QNCX is showing sideways momentum. The price is currently testing key support at $0.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: QNCX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+416.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, QNCX is showing sideways momentum. The price is currently testing key support at $0.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: QNCX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+416.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.93 -
$1.11
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 416.4% below Wall St target ($5.00)
Trading Range Analysis
30-Day Trading Range
$0.93 -
$1.11
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.27
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.36
Wall Street Target
$5.00
(+416.4%)
Share & Embed Analysis
Last updated: June 24, 2026 2:38 PM ET
Data refreshes hourly during market hours. Next update: 3:38 PM
Data refreshes hourly during market hours. Next update: 3:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 58 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 58 HOLD |
